| 1 | Profile A | Finished pharmaceutical manufacturer with sterile beta-lactam capability | Powder for solution for injection | 500 mg and 1 g, subject to product registration | Type I glass vial with sterile stopper | GMP certificate, Certificate of Analysis, stability data, batch release records | Confirm destination-market registration and authorized export documents | Due diligence required |
| 2 | Profile B | High-volume sterile injectable producer | Single-dose sterile powder vial | 500 mg, 750 mg, and 1 g where approved | Clear glass vial with aluminum seal | Validated aseptic-process summary, sterility test results, endotoxin results | Review inspection history and import-license requirements | Due diligence required |
| 3 | Profile C | Contract manufacturing organization for hospital injectables | Lyophilized or non-lyophilized sterile powder | Product-specific; commonly 500 mg or 1 g | Single vial or hospital pack | Technical agreement, process validation, cleaning validation, deviation history | Verify manufacturing-site authorization and batch-release responsibility | Due diligence required |
| 4 | Profile D | Penicillin-class injectable specialist | Amoxicillin sodium sterile powder for reconstitution | Strengths depend on approved product dossier | Type I molded or tubular glass vial | Pharmacopoeial compliance, assay, related substances, particulate-matter data | Check compliance with the buyer’s selected pharmacopoeia | Due diligence required |
| 5 | Profile E | Domestic hospital-supply manufacturer with export services | Ready-to-reconstitute injectable powder | Commonly supplied in 0.5 g and 1 g presentations | Vial with package insert and secondary carton | Artwork approval, labeling samples, CoA, product specification, retain-sample policy | Confirm English documentation and destination-language labeling capability | Due diligence required |
| 6 | Profile F | Private-label sterile dosage-form manufacturer | Custom-labeled powder for injection | Available only after technical and regulatory confirmation | Vial, carton, and shipper case configuration | Quality agreement, artwork control, change-control procedure, product dossier | Assess private-label ownership and registration transfer requirements | Due diligence required |
| 7 | Profile G | Small- and medium-batch sterile pharmaceutical producer | Hospital-use sterile powder vial | Usually offered in one or more registered strengths | Single-dose or multi-vial hospital packaging | Minimum batch size, release specification, sterility assurance, complaint procedure | Check production capacity, lead time, and continuity-of-supply controls | Due diligence required |
| 8 | Profile H | Integrated pharmaceutical group with internal quality-control laboratories | Sterile beta-lactam powder for injection | Product-specific and registration-dependent | Type I glass vial with tamper-evident seal | Finished-product specification, method validation, environmental-monitoring summary | Request recent GMP evidence and supply-chain traceability information | Due diligence required |
| 9 | Profile I | Export-oriented sterile pharmaceutical supplier | Powder for injection supplied in export cartons | Typically negotiated according to market authorization | Vial with multilingual packaging options | Free Sale Certificate where applicable, CoA, GMP evidence, shipping validation | Confirm cold-chain or controlled-temperature requirements, if applicable | Due diligence required |
| 10 | Profile J | Specialized injectable supplier offering regulatory support | Amoxicillin sodium sterile powder for reconstitution | Only use strengths supported by an approved dossier | Single-dose glass vial with patient-information materials | CTD documents, stability protocol, analytical methods, pharmacovigilance contact | Verify registration pathway, post-market obligations, and recall procedures | Due diligence required |